• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The incidence and impact of cardiac conduction disturbances after transcatheter aortic valve replacement.经导管主动脉瓣置换术后心脏传导障碍的发生率及影响
Ann Cardiothorac Surg. 2020 Nov;9(6):452-467. doi: 10.21037/acs-2020-av-23.
2
Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty): a retrospective cohort study.经导管主动脉瓣置换术后新发传导阻滞的预测因素:新一代自膨式瓣膜(VitaFlow Liberty)治疗单纯原发性主动脉瓣反流的回顾性队列研究。
BMC Cardiovasc Disord. 2024 Jan 28;24(1):77. doi: 10.1186/s12872-024-03735-z.
3
Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.经导管主动脉瓣置换术使用可重定位 LOTUS 装置后的传导异常和永久性起搏器植入:英国经验。
JACC Cardiovasc Interv. 2017 Jun 26;10(12):1247-1253. doi: 10.1016/j.jcin.2017.03.044.
4
Impact of baseline conduction abnormalities on outcomes after transcatheter aortic valve replacement with SAPIEN-3.基线传导异常对 SAPIEN-3 经导管主动脉瓣置换术后结局的影响。
Catheter Cardiovasc Interv. 2021 Jul 1;98(1):E127-E138. doi: 10.1002/ccd.29309. Epub 2020 Oct 3.
5
Incidence, Predictors, and Implications of Permanent Pacemaker Requirement After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后永久起搏器需求的发生率、预测因素及其影响。
JACC Cardiovasc Interv. 2021 Jan 25;14(2):115-134. doi: 10.1016/j.jcin.2020.09.063.
6
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.经导管主动脉瓣置换术后新发左束支传导阻滞与中危患者不良长期临床结局相关:来自 PARTNER II 试验的分析。
Eur Heart J. 2019 Jul 14;40(27):2218-2227. doi: 10.1093/eurheartj/ehz227.
7
Electrophysiologic Implications of Transcatheter Aortic Valve Replacement: Incidence, Outcomes, and Current Management Strategies.经导管主动脉瓣置换术的电生理影响:发生率、结局和当前管理策略。
Curr Cardiol Rep. 2021 Oct 1;23(11):167. doi: 10.1007/s11886-021-01599-9.
8
A single-centre cohort and short-term follow-up of patients who developed persistent new onset left bundle branch block after transcatheter aortic valve replacement.经导管主动脉瓣置换术后持续性新发左束支传导阻滞患者的单中心队列和短期随访。
Acta Cardiol. 2020 Aug;75(4):360-365. doi: 10.1080/00015385.2020.1713520. Epub 2020 Jan 26.
9
Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives.经导管主动脉瓣置换术后传导障碍:现状与未来展望。
Circulation. 2017 Sep 12;136(11):1049-1069. doi: 10.1161/CIRCULATIONAHA.117.028352.
10
How does new-onset left bundle branch block affect the outcomes of transcatheter aortic valve repair?新发左束支传导阻滞如何影响经导管主动脉瓣修复术的结局?
Expert Rev Med Devices. 2019 Jul;16(7):589-602. doi: 10.1080/17434440.2019.1624161. Epub 2019 Jun 7.

引用本文的文献

1
The Role of 6-Hour ECG in Patients with Left Bundle Branch Block After TAVI in Determining Same-Day Discharge.6小时心电图在经导管主动脉瓣置换术后左束支传导阻滞患者确定当日出院中的作用
J Clin Med. 2025 Jul 31;14(15):5408. doi: 10.3390/jcm14155408.
2
Anatomical features of aortic root in patients with aortic stenosis treated by TAVR: an observational study.经导管主动脉瓣置换术治疗的主动脉瓣狭窄患者主动脉根部的解剖特征:一项观察性研究。
BMC Med Imaging. 2025 Aug 12;25(1):326. doi: 10.1186/s12880-025-01867-y.
3
TAVI PATIENT WITH RCA DISSECTION, POST-TAVR HIGH DEGREE AV BLOCK AND ACUTE NEUROLOGICAL INJURY.经导管主动脉瓣置入术患者合并右冠状动脉夹层、术后高度房室传导阻滞及急性神经损伤
Acta Clin Croat. 2024 Mar;63(Suppl1):111-115. doi: 10.20471/acc.2024.63.s1.21.
4
A Two-Step Risk Score for Prediction of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后永久性起搏器植入预测的两步风险评分
J Am Heart Assoc. 2025 May 20;14(10):e039036. doi: 10.1161/JAHA.124.039036. Epub 2025 May 15.
5
Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve implantation.经导管主动脉瓣置换术后永久起搏器植入的预测因素和临床转归。
BMC Cardiovasc Disord. 2024 Aug 24;24(1):448. doi: 10.1186/s12872-024-04101-9.
6
Predictors, clinical impact, and management strategies for conduction abnormalities after transcatheter aortic valve replacement: an updated review.经导管主动脉瓣置换术后传导异常的预测因素、临床影响及管理策略:最新综述
Front Cardiovasc Med. 2024 Apr 8;11:1370244. doi: 10.3389/fcvm.2024.1370244. eCollection 2024.
7
Lower incidence of new-onset severe conduction disturbances after transcatheter aortic valve implantation with bicuspid aortic valve in patients with no baseline conduction abnormality: a cross-sectional investigation in a single center in China.无基线传导异常的二叶式主动脉瓣患者经导管主动脉瓣植入术后新发严重传导障碍的发生率较低:中国单中心横断面研究
Front Cardiovasc Med. 2023 Jun 27;10:1176984. doi: 10.3389/fcvm.2023.1176984. eCollection 2023.
8
Transcatheter Aortic Valve Implantation: Addressing the Subsequent Risk of Permanent Pacemaker Implantation.经导管主动脉瓣植入术:应对永久起搏器植入的后续风险
J Cardiovasc Dev Dis. 2023 May 24;10(6):230. doi: 10.3390/jcdd10060230.
9
Iatrogenic Aorto-Right Ventricular Fistula: A Rare Complication of Transcatheter Valve Implantation.医源性主动脉-右心室瘘:经导管瓣膜植入术的一种罕见并发症。
CASE (Phila). 2023 Mar 13;7(5):197-204. doi: 10.1016/j.case.2023.01.002. eCollection 2023 May.
10
Patient-Specific Computer Simulation to Predict Conduction Disturbance With Current-Generation Self-Expanding Transcatheter Heart Valves.利用当代自膨胀经导管心脏瓣膜进行特定患者计算机模拟以预测传导障碍
Struct Heart. 2022 Mar 29;6(3):100010. doi: 10.1016/j.shj.2022.100010. eCollection 2022 Jul.

本文引用的文献

1
Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve: A Propensity-Matched Analysis From the United States.真实世界中应用 SAPIEN 3 Ultra 经导管心脏瓣膜的经验:来自美国的倾向评分匹配分析。
Circ Cardiovasc Interv. 2021 Sep;14(9):e010543. doi: 10.1161/CIRCINTERVENTIONS.121.010543. Epub 2021 Aug 26.
2
Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation.经 Evolut 经导管主动脉瓣置换术后新发持续性左束支传导阻滞的新解剖学预测因素。
Am J Cardiol. 2020 Apr 15;125(8):1222-1229. doi: 10.1016/j.amjcard.2020.01.008. Epub 2020 Jan 30.
3
Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry.三代自膨式经导管主动脉瓣:STS/ACC TVT 注册研究报告。
JACC Cardiovasc Interv. 2020 Jan 27;13(2):170-179. doi: 10.1016/j.jcin.2019.08.035.
4
Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.经导管主动脉瓣置换术患者传导障碍的临床影响:一项系统评价和荟萃分析。
Eur Heart J. 2020 Aug 1;41(29):2771-2781. doi: 10.1093/eurheartj/ehz924.
5
Relevance of New Conduction Disorders After Implantation of the ACURATE Neo Transcatheter Heart Valve in the Aortic Valve Position.经导管主动脉瓣置换术后新发传导障碍与 ACURATE Neo 瓣膜植入的相关性研究
Am J Cardiol. 2020 Mar 1;125(5):783-787. doi: 10.1016/j.amjcard.2019.11.036. Epub 2019 Dec 14.
6
In-hospital and thirty-day outcomes of the SAPIEN 3 Ultra balloon-expandable transcatheter aortic valve: the S3U registry.《SAPIEN 3 Ultra 球囊扩张式经导管主动脉瓣:S3U 注册研究》:院内和 30 天预后。
EuroIntervention. 2020 Feb 20;15(14):1240-1247. doi: 10.4244/EIJ-D-19-00541.
7
Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis: Data From a Nationwide Analysis.Sapien 3 球囊扩张式与 Evolut R 自膨式经导管主动脉瓣置换术治疗主动脉瓣狭窄患者的影响:来自全国性分析的数据。
Circulation. 2020 Jan 28;141(4):260-268. doi: 10.1161/CIRCULATIONAHA.119.043971. Epub 2019 Nov 16.
8
Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial.在 REPRISE III 试验中经导管主动脉瓣置换术后起搏器植入和依赖情况。
J Am Heart Assoc. 2019 Nov 5;8(21):e012594. doi: 10.1161/JAHA.119.012594. Epub 2019 Oct 23.
9
Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.经导管主动脉瓣置换术中自膨式与球囊扩张式生物瓣治疗有症状重度主动脉瓣狭窄患者的安全性和疗效:一项随机非劣效性试验。
Lancet. 2019 Nov 2;394(10209):1619-1628. doi: 10.1016/S0140-6736(19)32220-2. Epub 2019 Sep 27.
10
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.经导管主动脉瓣置换术后新发左束支传导阻滞与中危患者不良长期临床结局相关:来自 PARTNER II 试验的分析。
Eur Heart J. 2019 Jul 14;40(27):2218-2227. doi: 10.1093/eurheartj/ehz227.

经导管主动脉瓣置换术后心脏传导障碍的发生率及影响

The incidence and impact of cardiac conduction disturbances after transcatheter aortic valve replacement.

作者信息

Chen Shmuel, Chau Katherine H, Nazif Tamim M

机构信息

Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, USA.

出版信息

Ann Cardiothorac Surg. 2020 Nov;9(6):452-467. doi: 10.21037/acs-2020-av-23.

DOI:10.21037/acs-2020-av-23
PMID:33312903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7724062/
Abstract

Transcatheter aortic valve replacement (TAVR) has developed into an established therapy for patients with severe aortic stenosis (AS) across the spectrum of surgical risk. Despite improvements in transcatheter heart valve (THV) technologies and procedural techniques, cardiac conduction disturbances, including high degree atrioventricular block (AVB) requiring permanent pacemaker (PPM) implantation and new-onset left bundle branch block (LBBB), remain frequent complications. TAVR-related conduction disturbances occur due to injury to the conduction system from interactions with interventional equipment and the transcatheter valve stent frame. Risk factors for post-TAVR conduction disturbances have been identified and include clinical characteristics, baseline electrocardiogram findings (right bundle branch block), anatomic factors, and potentially modifiable procedural factors (type of transcatheter valve, depth of implantation, over-sizing). New-onset LBBB and PPM implantation after TAVR have been shown to be associated with adverse long-term clinical outcomes, including mortality and heart failure hospitalization. These clinical consequences are likely to be of increasing importance as TAVR is utilized in younger and lower risk population. This review provides an updated overview of the literature regarding the incidence, predictors, and clinical outcomes of TAVR-related conduction disturbances, as well as proposed strategies for the management of this frequent clinical challenge.

摘要

经导管主动脉瓣置换术(TAVR)已发展成为一种针对不同手术风险的重度主动脉瓣狭窄(AS)患者的成熟治疗方法。尽管经导管心脏瓣膜(THV)技术和手术操作技术有所改进,但心脏传导障碍,包括需要植入永久起搏器(PPM)的高度房室传导阻滞(AVB)和新发左束支传导阻滞(LBBB),仍然是常见的并发症。TAVR相关的传导障碍是由于介入设备和经导管瓣膜支架框架相互作用对传导系统造成损伤所致。已确定TAVR后传导障碍的危险因素,包括临床特征、基线心电图表现(右束支传导阻滞)、解剖因素以及可能可改变的手术因素(经导管瓣膜类型、植入深度、尺寸过大)。TAVR后新发LBBB和PPM植入已被证明与不良的长期临床结局相关,包括死亡率和心力衰竭住院率。随着TAVR应用于更年轻、风险更低的人群,这些临床后果可能会变得越来越重要。本综述提供了关于TAVR相关传导障碍的发生率、预测因素和临床结局的文献最新概述,以及针对这一常见临床挑战的管理建议策略。